Bortezomib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Bortezomib
Jun 29, 2024, 13:39 |
Insight
Myeloma Paper of the Day, June 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Real-world analysis of renally impaired…
Jun 20, 2024, 12:25 |
Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
Jun 7, 2024, 16:50 |
Insight
Myeloma Paper of the Day, June 7th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Response rate and EFS to…
Jun 5, 2024, 14:51 |
Blog
Diko Kazandjian: IsaVRD more is better
Dickran (Diko) Kazandjian, Professor of Medicine at the Sylvester Comprehensive Cancer Center and Board Member…
Jun 4, 2024, 14:44 |
Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
May 14, 2024, 16:12 |
Insight
Myeloma Paper of the Day, May 14th, suggester by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 8, 2024, 02:28 |
Insight
Myeloma Paper of the Day, May 7th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
Apr 20, 2024, 05:56 |
Insight
Myeloma Paper of the Day suggested by Robert Orlowski, April 18th
Robert Orlowski, Director of the Myeloma Section at MD Anderson Cancer Center, shared on X:…
Mar 1, 2024, 18:37 |
Drugs
Vincent Rajkumar: How many years of life gained because of FDA accelerated approval in myeloma?
Vincent Rajkumar, Editor-in-Chief at the Blood Cancer Journal, shared a thread on X/Twitter: "How many…
1
2
All:
13
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube